$2 billion surgical tech company, PolyNovo, signed a deal with Premier Inc, a major US group purchasing organisation for the supply of NovoSorb BTM, under their "Breakthrough Technology Program". The program ensures member hospitals have timely access to innovative products. The agreement allows Premier member hospitals access to BTM at the special pricing and terms negotiated with PolyNovo.
Polynovo's core product, Novosorb, takes a variety of forms and can be used by surgeons as ‘scaffolding’ to help build and repair skin after surgery or serious burns. The deal will see Polynovo delivering these products and education about their use to health providers in the Premier network.
Premier services roughly 4100 health facilities and hospital members, including:
Over 2000 acute care hospitals including 100 designated trauma centres
63 Children’s hospitals including 20 designated as trauma and/or burn centres.
From April 1, PolyNovo will have access to Premier member hospitals and regional representatives, responsible for introducing new technology. PolyNovo’s team will provide training, materials and support to facilitate the uptake of NovoSorb BTM. While their sales team will be able to enter hospitals that were previously restricted and will have a streamlined procurement process to facilitate faster adoption.
Managing Director of PolyNovo, Paul Brennan said, “This signing with Premier, the second-largest GPO in the US, is a major milestone. We have recently signed with Aptitude and First Choice. These GPO agreements put our disruptive BTM on a much larger list of hospitals than our sales team can get around in the short term. We will continue expanding our sales team into new markets to support hospitals and surgeons but now also to match the geographical footprint of the GPOs. We look forward to demonstrating improved health economic benefits for Premier hospital members and their patients.”